Senior insider sale
Chief Medical Officer at RELMADA THERAPEUTICS, INC. — senior position signals high conviction
$442.5K
75K shares
What this filing means
O'GORMAN CEDRIC plans to sell 75K shares of RELMADA THERAPEUTICS, INC. valued at approximately $442.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/20/2024ACC: 0001972362-24-000160
Officer· Chief Medical Officer
Since Jan 2023
75K
Shares to sell
$442.5K
Approx. market value
75K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
COMPENSATION
2/20/2024
75KTotal acquired75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/20/2024 | STOCK OPTION EXERCISE COMPENSATION | 75K | — |
| Total | 75K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
75K
Market value
$442.5K
2/20/2024
Total
Units
75K
Value
$442.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/20/2024 | 75K | $442.5K | NASDAQ | Planned |
| Total | 75K | $442.5K | ||